Trials / Unknown
UnknownNCT05683561
A Phase III Clinical Trial to Evaluate the Efficacy and Safety of SCTV01E in Healthy People
A Randomized, Double-blind, Positive-controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of SCTV01E (A COVID-19 Alpha/Beta/Delta/Omicron Variants S-Trimer Vaccine) in Healthy People
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 6,000 (estimated)
- Sponsor
- Sinocelltech Ltd. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The objective of this study is to evaluate the effectiveness of SCTV01E in healthy people
Detailed description
The study is a randomized, double-blind, placebo-controlled Phase III study. It will evaluate the protective effectiveness and safety of SCTV01E against COVID-19 in participants who were previously received primary series or booster dose of COVID-19 vaccines.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | CoronaVac | D0; intramuscular injection |
| BIOLOGICAL | SCTV01E | D0; intramuscular injection |
Timeline
- Start date
- 2023-01-25
- Primary completion
- 2023-08-25
- Completion
- 2024-08-25
- First posted
- 2023-01-13
- Last updated
- 2023-01-13
Source: ClinicalTrials.gov record NCT05683561. Inclusion in this directory is not an endorsement.